GlaxoSmithKline Notes Approval Of HIV Drug Dovato In US
LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said Dovato has been approved in the US as a treatment for HIV-1 infection in adults who have not previously been treated with antiretroviral
